Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for doxorubicin induced cardiomyopathy has been reported in the published literature.
2 clinical trials registered, 1 recruiting. Interventions under study include drug therapy. Pipeline includes 1 PHASE2, 1 PHASE1. Research is primarily sponsored by academic and government institutions.
81 publications have been identified in PubMed for doxorubicin induced cardiomyopathy. Research spans Basic Science / Preclinical (75%), Review / Meta-Analysis (12%), and Gene Therapy / Novel Therapeutics (4%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 61 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:57 PM UTC
Genetic and Rare Diseases Info Center
Research summaries | 10 | 12% |
New treatment approaches | 3 | 4% |
Other research | 2 | 2% |
Testing and diagnosis research | 2 | 2% |
Patient case studies | 1 | 1% |
Clinical study results | 1 | 1% |
Disease patterns and progression | 1 | 1% |
Malik A (2026). [PMID: 42057146](https://pubmed.ncbi.nlm.nih.gov/42057146/). *J Cell Mol Med*. [Basic Science / Preclinical]
Chen L (2026). [PMID: 41942611](https://pubmed.ncbi.nlm.nih.gov/41942611/). *Br J Cancer*. [Basic Science / Preclinical]
Goyal G (2026). [PMID: 41217853](https://pubmed.ncbi.nlm.nih.gov/41217853/). *Chem Biodivers*. [Basic Science / Preclinical]
Feder AL (2026). [PMID: 41438497](https://pubmed.ncbi.nlm.nih.gov/41438497/). *J Mol Cell Cardiol Plus*. [Basic Science / Preclinical]
Chen G (2026). [PMID: 41729374](https://pubmed.ncbi.nlm.nih.gov/41729374/). *Inflammation*. [Basic Science / Preclinical]
Liu S (2026). [PMID: 41963318](https://pubmed.ncbi.nlm.nih.gov/41963318/). *Nat Commun*. [Basic Science / Preclinical]
Chao P (2026). [PMID: 41670032](https://pubmed.ncbi.nlm.nih.gov/41670032/). *ACS Appl Mater Interfaces*. [Basic Science / Preclinical]
Sawasaki F (2026). [PMID: 41177180](https://pubmed.ncbi.nlm.nih.gov/41177180/). *Biochem Pharmacol*. [Basic Science / Preclinical]
Drumeva GO (2026). [PMID: 41943119](https://pubmed.ncbi.nlm.nih.gov/41943119/). *Cardiooncology*. [Basic Science / Preclinical]
Le Y (2026). [PMID: 42176508](https://pubmed.ncbi.nlm.nih.gov/42176508/). *Phytomedicine*. [Basic Science / Preclinical]